Prosecution Insights
Last updated: October 02, 2026
Application No. 18/313,831

FIXATION COMPONENT FOR MULTI-ELECTRODE IMPLANTABLE MEDICAL DEVICE

Non-Final OA §102
Filed
May 08, 2023
Priority
Aug 13, 2019 — provisional 62/885,843 +1 more
Examiner
LEVICKY, WILLIAM J
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Inc.
OA Round
2 (Non-Final)
69%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
411 granted / 592 resolved
-0.6% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
34 currently pending
Career history
648
Total Applications
across all art units

Statute-Specific Performance

§101
8.3%
-31.7% vs TC avg
§103
41.3%
+1.3% vs TC avg
§102
16.9%
-23.1% vs TC avg
§112
25.7%
-14.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 592 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after allowance or after an Office action under Ex Parte Quayle, 25 USPQ 74, 453 O.G. 213 (Comm'r Pat. 1935). Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, prosecution in this application has been reopened pursuant to 37 CFR 1.114. Applicant's submission filed on 7/9/2026 has been entered. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 7-11, 16, and 17 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bonner et al (US Patent 10,238,865), cited in IDS filed 7/9/2026. Referring to Claim 1, Bonner et al teaches a fixation component for an implantable medical device (IMD), comprising: a base defining a longitudinal axis of the fixation component, wherein the base is configured to be fixedly attached to the IMD (e.g. Figure 3A with base 311); and a plurality of tines (e.g. Figures 3A-3B, tines 341 and 342) configured to affix the fixation component to a tissue, wherein each tine of the plurality of tines defines a proximal section extending distally from the base and a second section extending laterally from the proximal section along a reference plane transverse to the longitudinal axis in a same direction relative to the base (e.g. Figure 3, tines 341 and 34a). Referring to Claim 7, Bonner et al teaches the fixation component of claim 1, wherein the same direction comprises a first direction, wherein the second section of each tine of the plurality of tines comprises a distal section of the each tine, wherein the proximal section of each tine of the plurality of tines extends distally from the base and in a second direction, and wherein a curved section of each tine of the plurality of tines extends from the proximal section of each tine to the distal section of each tine extending along the reference plane in the first direction, and wherein the first direction is different from the second direction (e.g. Figure 3A tines 341 and 342). Referring to Claim 8, Bonner et al teaches the fixation component of claim 7, wherein a reference axis extending along the first direction is parallel to the longitudinal axis, the reference axis being separate from the reference plane (e.g. Figure 3A). Referring to Claim 9, Bonner et al teaches the fixation component of claim 7, wherein a reference axis extending along the first direction is separated from the longitudinal axis by an angle of up to 5 degrees (e.g. Figure 3A). Referring to Claim 10, Bonner et al teaches the fixation component of claim 7, wherein the first direction and the second direction are separated by an angle of 90 degrees to 145 degrees relative to the longitudinal axis (e.g. Figure 3A). Referring to Claim 11, Bonner et al teaches an implantable medical device (IMD), comprising :a housing extending along a longitudinal axis from a proximal end to a distal end (e.g. Figures 3A, 3B, and 8, housing 310); an elongate leadlet mounted in proximity to the distal end of the housing and extending distally from the housing, wherein a distal end of the leadlet comprises a first electrode (e.g. Figures 3A, 3B, and 8, electrode 32); a second electrode mounted in proximity to the distal end of the housing (e.g. Figure 8, electrode 82); and a fixation component comprising: a base defining a longitudinal axis of the fixation component, wherein the base is configured to be fixedly attached to the IMD (e.g. Figures 3A, 3B, and 8, base 311); and wherein each tine of the plurality of tines defines a proximal section extending distally from the base and a second section extending laterally from the proximal section along a reference plane transverse to the longitudinal axis in a same direction relative to the base (e.g. Figures 3A, 3B, and 8 tines 341 and 342). Referring to Claim 16, Bonner et al teaches the IMD of claim 11, wherein the same direction comprises a first direction, wherein the second section of each tine of the plurality of tines comprises a distal section of the each tine, wherein the proximal section of each tine of the plurality of tines extends distally from the base and in a second direction, and wherein a curved section of each tine of the plurality of tines extends from the proximal section of each tine extending from the proximal section of each tine and a to the distal section of each tine extending along the reference plane in the first direction, wherein the first direction is different from the second direction (e.g. Figure 3A tines 341 and 342). Referring to Claim 17, Bonner et al teaches a medical device system comprising: an implantable medical device (IMD) comprising: a housing extending along a longitudinal axis from a proximal end to a distal end (e.g. Figures 3A, 3B, and 8, housing 310); an elongate leadlet mounted in proximity to the distal end of the housing and extending distally from the housing, wherein a distal end of the leadlet comprises a first electrode (e.g. Figures 3A, 3B, and 8, electrode 32); a second electrode mounted in proximity to the distal end of the housing (e.g. Figure 8, electrode 82); and a fixation component comprising a base in proximity to the distal end of the housing (e.g. Figures 3A, 3B, and 8, base 311), and a plurality of tines fixedly attached spaced from one another around a perimeter of the distal end of the housing, wherein each tine of the plurality of tines defines a first section extending distally from the base and a second section extending from the first section (e.g. Figures 3A, 3B, and 8 tines 341 and 342); and a delivery tool comprising a tubular sidewall that defines a lumen into which the IMD may be loaded, wherein the lumen having a distal opening through which the IMD may be deployed, and wherein the delivery tool is configured to retain the plurality of tines in a deformed configuration (e.g. Figures 5A and 5C, delivery tool 500 and Column 5 lines 52-Column 6 line 5), wherein when the plurality of tines is within an undeformed configuration outside of the delivery tool, the second section of each tine of the plurality of tines extends laterally from the proximal section along a reference plane transverse to the longitudinal axis in a same direction relative to the base (e.g. Figures 3A, 3B, and 8 tines 341 and 342). Allowable Subject Matter Claims 2-5, 12-15, and 18-20 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Eggen et al (US Publication 2016/0059003) discloses a fixation element with a base and a plurality of tines wherein the plurality of tines define a proximal section extending distally form the base and a section extending laterally form the proximal section along a reference plane transverse to the longitudinal axis. Any inquiry concerning this communication or earlier communications from the examiner should be directed to William J Levicky whose telephone number is (571)270-3983. The examiner can normally be reached Monday-Thursday 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /William J Levicky/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

May 08, 2023
Application Filed
Oct 08, 2025
Non-Final Rejection mailed — §102
Jan 05, 2026
Response Filed
Jul 09, 2026
Request for Continued Examination
Jul 18, 2026
Response after Non-Final Action
Sep 08, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746397
BIORESORBABLE CARDIOVASCULAR INSTRUMENTS, AND OPERATION AND FABRICATION METHODS OF SAME
2y 9m to grant Granted Sep 29, 2026
Patent 12728275
COMBINED IMPLANTABLE PULSE GENERATOR DEVICE
3y 3m to grant Granted Sep 08, 2026
Patent 12727750
SYSTEMS AND METHODS FOR OPTICAL FILTER DETECTION AND IDENTIFICATION
2y 8m to grant Granted Sep 08, 2026
Patent 12721995
THERAPEUTIC ELECTRICAL MUSCLE STIMULATION APPARATUS AND METHOD OF TREATMENT
2y 11m to grant Granted Sep 01, 2026
Patent 12708775
STOCHASTIC STIMULATION SCHEDULING
3y 4m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
69%
Grant Probability
99%
With Interview (+29.7%)
3y 4m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 592 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month